查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947913

腸道疾病檢測市場分析及預測（至2035年）：依類型、產品、服務、技術、應用、最終使用者、流程、功能及安裝類型分類

Enteric Disease Testing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Process, Functionality, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 344 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計腸道疾病檢測市場規模將從2024年的36億美元成長到2034年的56億美元，複合年成長率約為2.7%。該市場涵蓋用於檢測引起疾病的消化器官系統病原體（例如沙門氏菌、大腸桿菌和諾羅病毒）的診斷工具和技術。市場包括快速檢測、分子診斷和基於培養的方法。食源性疾病發生率的上升和衛生意識的增強是推動市場成長的主要因素。監管標準和對高效疾病控制的需求正在推動技術創新，旨在提高全球醫療機構和實驗室的檢測準確性、速度和易用性。

由於診斷技術的進步和人們對腸道感染疾病的認知不斷提高，腸道疾病檢測市場正經歷強勁成長。分子診斷領域憑藉其高準確性和快速出結果的優勢，展現出最高的成長率。基於PCR的檢測和次世代定序是提升檢測能力的關鍵技術。免疫檢測是成長第二快的領域，由於其成本效益高且易於使用，已被廣泛應用於臨床。 PCR檢測憑藉其高準確性在分子診斷領域佔據主導地位。同時，快速免疫檢測在免疫檢測領域也佔據主導地位。在各種情況下對快速準確結果的需求推動了就地檢驗的需求。自動化檢測解決方案因其能夠簡化工作流程並減少人為錯誤而備受關注。研發投入的不斷增加正在推動創新，帶來新的生物標記和先進的檢測方法。這些趨勢凸顯了市場的活力和盈利的潛在商機。

市場區隔
按類型 細菌、病毒和寄生蟲檢測
產品 試劑/試劑盒、設備、軟體
服務 檢查服務、診斷服務
科技 分子診斷、免疫檢測、傳統培養方法、快速檢測
目的 臨床診斷、環境檢測、食品安全
最終用戶 醫院和診所、診斷檢查室實驗室、食品和飲料行業
流程 檢體採集、樣本製備、檢測與分析
功能 全自動、半自動、手動
安裝類型 桌面式和可攜式

腸道疾病檢測市場正經歷強勁成長，這主要得益於創新產品的推出和動態定價策略的推動。主要企業正透過在其產品組合中添加先進的診斷技術來拓展業務，這些技術承諾提供快速且準確的檢測結果。這種策略擴張輔以旨在獲取更大市場佔有率的競爭性定價模式。策略聯盟和併購進一步影響市場的競爭格局，從而創造了一個有利於創新和市場滲透的環境。腸道疾病檢測市場的競爭異常激烈，主要企業正透過技術創新和策略聯盟爭奪主導。法規結構，尤其是在北美和歐洲，對於塑造市場動態和確保符合嚴格的品質標準至關重要。這些法規促進了創新，提高了產品功效，並增強了消費者信心。儘管市場高度分散，但新興市場和技術整合仍蘊藏著巨大的成長機會。隨著不斷變化的法規和競爭策略塑造市場的未來發展軌跡，市場環境仍然充滿活力。

主要趨勢和促進因素：

由於全球胃腸道感染疾病率不斷上升，腸道疾病檢測市場正經歷強勁成長。人們對食品安全和衛生意識的提高推動了對先進診斷解決方案的需求。關鍵趨勢包括分子診斷技術的應用，該技術能夠快速且準確地檢測病原體。人工智慧與診斷工具的融合提高了檢測的準確性和效率。此外，就地檢驗的普及正在改變市場格局，實現及時診斷和治療。受消費者對便利性和隱私性的偏好驅動，家用檢測套組的普及勢頭強勁。政府遏制感染疾病的舉措進一步推動了市場成長。此外，對個人化醫療的日益重視也推動了客製化檢測解決方案的開發。新興市場醫療基礎設施的不斷完善蘊藏著許多機會。投資於創新技術和策略合作的公司將能夠更好地掌握這些趨勢，確保市場永續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 細菌學檢測
    • 病毒檢測
    • 寄生蟲檢測
  • 市場規模及預測：依產品分類
    • 試劑和試劑盒
    • 裝置
    • 軟體
  • 市場規模及預測：依服務分類
    • 體檢服務
    • 診斷服務
  • 市場規模及預測：依技術分類
    • 分子診斷
    • 免疫檢測
    • 傳統培養方法
    • 快速檢測
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 環境檢查
    • 食品安全
  • 市場規模及預測：依最終用戶分類
    • 醫院和診所
    • 診斷檢查室
    • 研究所
    • 食品飲料業
  • 市場規模及預測：依製程分類
    • 檢體採集
    • 樣品製備
    • 偵測
    • 分析
  • 市場規模及預測：依功能分類
    • 自動的
    • 半自動
    • 手動的
  • 市場規模及預測：依安裝類型分類
    • 桌面型
    • 攜帶式的

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Bio-Rad Laboratories
  • Dia Sorin
  • Quidel Ortho Corporation
  • Meridian Bioscience
  • Luminex Corporation
  • Gen Mark Diagnostics
  • Alere
  • Ora Sure Technologies
  • Chembio Diagnostic Systems
  • Trinity Biotech
  • Sekisui Diagnostics
  • EKF Diagnostics
  • Thermo Fisher Scientific
  • T2 Biosystems
  • Becton Dickinson
  • Cepheid
  • Roche Diagnostics
  • bio Merieux
  • Hologic
  • Abbott Laboratories

第9章：關於我們

簡介目錄
Product Code: GIS21027

Enteric Disease Testing Market is anticipated to expand from $3.6 billion in 2024 to $5.6 billion by 2034, growing at a CAGR of approximately 2.7%. The Enteric Disease Testing Market encompasses diagnostic tools and technologies designed to detect gastrointestinal pathogens causing diseases such as salmonella, E. coli, and norovirus. This market includes rapid tests, molecular diagnostics, and culture-based methods. Rising incidence of foodborne illnesses and increasing awareness about hygiene propel market growth. Innovations focus on enhancing accuracy, speed, and ease of use, catering to healthcare facilities and laboratories worldwide, driven by regulatory standards and the need for efficient disease management.

The Enteric Disease Testing Market is experiencing robust growth, propelled by advancements in diagnostic technologies and increasing awareness of enteric diseases. The molecular diagnostics segment is the top performer, driven by its high accuracy and rapid results. PCR-based tests and next-generation sequencing are pivotal, enhancing detection capabilities. Immunoassays follow closely, reflecting their widespread use in clinical settings for their cost-effectiveness and ease of use. Within molecular diagnostics, PCR tests dominate due to their precision, while rapid immunoassays lead in the immunoassay category. The demand for point-of-care testing is rising, driven by the need for quick and accurate results in diverse settings. Automated testing solutions are gaining traction, improving workflow efficiency and reducing human error. Increased investment in research and development is fostering innovation, with novel biomarkers and advanced detection methods on the horizon. These trends underscore the market's dynamic nature and potential for lucrative opportunities.

Market Segmentation
TypeBacterial Testing, Viral Testing, Parasitic Testing
ProductReagents and Kits, Instruments, Software
ServicesConsulting Services, Diagnostic Services
TechnologyMolecular Diagnostics, Immunoassays, Traditional Cultures, Rapid Tests
ApplicationClinical Diagnostics, Environmental Testing, Food Safety
End UserHospitals and Clinics, Diagnostic Laboratories, Research Institutes, Food and Beverage Industry
ProcessSample Collection, Sample Preparation, Detection, Analysis
FunctionalityAutomated, Semi-Automated, Manual
Installation TypeBench-top, Portable

The Enteric Disease Testing Market is witnessing robust growth, propelled by innovative product launches and dynamic pricing strategies. Leading companies are expanding their portfolios to include advanced diagnostic technologies that promise rapid and accurate results. This strategic expansion is complemented by competitive pricing models designed to capture a larger market share. The market's competitive landscape is further influenced by strategic alliances and mergers, fostering a climate of innovation and market penetration. Competition in the Enteric Disease Testing Market is intense, with key players vying for dominance through technological advancements and strategic partnerships. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market dynamics and ensuring compliance with stringent quality standards. These regulations drive innovation and enhance product efficacy, fostering consumer trust. The market is characterized by a high degree of fragmentation, yet opportunities abound for growth through emerging markets and technological integration. The landscape remains dynamic, with evolving regulations and competitive strategies shaping future trajectories.

Geographical Overview:

The enteric disease testing market is experiencing notable growth across various regions, each exhibiting unique characteristics. North America leads the market, driven by advanced healthcare infrastructure and increased awareness of enteric diseases. The prevalence of gastrointestinal infections in the region further accelerates demand for effective testing solutions. Europe follows as a significant player, with strong emphasis on public health initiatives and stringent regulatory frameworks. This ensures high standards in diagnostic testing and fosters market expansion. Asia Pacific is witnessing rapid growth, propelled by rising healthcare investments and increasing incidence of enteric diseases. The region's improving healthcare access further boosts market potential. Latin America and the Middle East & Africa are emerging markets with promising prospects. In Latin America, growing healthcare expenditure and awareness campaigns are enhancing market growth. Meanwhile, the Middle East & Africa are recognizing the importance of enteric disease testing in improving public health outcomes, paving the way for future opportunities.

The enteric disease testing market is navigating a complex landscape of global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, heightened trade tensions prompt a strategic pivot towards enhancing domestic production capacities and reducing dependency on imports. China is accelerating its investment in biotechnological self-reliance to mitigate the impact of foreign tariffs and sanctions. Taiwan, while maintaining its critical role in the technology supply chain, faces geopolitical vulnerabilities that necessitate strategic alliances and diversification. Globally, the parent market is robust, driven by increasing demand for rapid diagnostics and public health initiatives. By 2035, the market is expected to evolve with advancements in molecular diagnostics and AI integration. Middle East conflicts may indirectly affect global supply chains through energy price volatility, influencing production costs and logistics.

Key Trends and Drivers:

The enteric disease testing market is experiencing robust growth, driven by rising incidences of gastrointestinal infections globally. Increasing awareness about food safety and hygiene is propelling demand for advanced diagnostic solutions. Key trends include the adoption of molecular diagnostic techniques, offering rapid and accurate pathogen detection. The integration of artificial intelligence in diagnostic tools is enhancing test precision and efficiency. Moreover, the expansion of point-of-care testing is transforming the market landscape, enabling timely diagnosis and treatment. The shift towards home-based testing kits is gaining traction, fueled by consumer preference for convenience and privacy. Government initiatives to curb infectious diseases are further stimulating market growth. Additionally, the growing focus on personalized medicine is fostering the development of tailored testing solutions. Opportunities abound in emerging markets, where healthcare infrastructure is expanding. Companies investing in innovative technologies and strategic partnerships are well-positioned to capitalize on these trends, ensuring sustained market momentum.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Installation Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Bacterial Testing
    • 4.1.2 Viral Testing
    • 4.1.3 Parasitic Testing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents and Kits
    • 4.2.2 Instruments
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Diagnostic Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassays
    • 4.4.3 Traditional Cultures
    • 4.4.4 Rapid Tests
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Environmental Testing
    • 4.5.3 Food Safety
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Clinics
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Food and Beverage Industry
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Sample Collection
    • 4.7.2 Sample Preparation
    • 4.7.3 Detection
    • 4.7.4 Analysis
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Automated
    • 4.8.2 Semi-Automated
    • 4.8.3 Manual
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 Bench-top
    • 4.9.2 Portable

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Functionality
      • 5.2.1.9 Installation Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Functionality
      • 5.2.2.9 Installation Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Functionality
      • 5.2.3.9 Installation Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Functionality
      • 5.3.1.9 Installation Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Functionality
      • 5.3.2.9 Installation Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Functionality
      • 5.3.3.9 Installation Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Functionality
      • 5.4.1.9 Installation Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Functionality
      • 5.4.2.9 Installation Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Functionality
      • 5.4.3.9 Installation Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Functionality
      • 5.4.4.9 Installation Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Functionality
      • 5.4.5.9 Installation Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Functionality
      • 5.4.6.9 Installation Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Functionality
      • 5.4.7.9 Installation Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Functionality
      • 5.5.1.9 Installation Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Functionality
      • 5.5.2.9 Installation Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Functionality
      • 5.5.3.9 Installation Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Functionality
      • 5.5.4.9 Installation Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Functionality
      • 5.5.5.9 Installation Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Functionality
      • 5.5.6.9 Installation Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Functionality
      • 5.6.1.9 Installation Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Functionality
      • 5.6.2.9 Installation Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Functionality
      • 5.6.3.9 Installation Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Functionality
      • 5.6.4.9 Installation Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Functionality
      • 5.6.5.9 Installation Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bio- Rad Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Dia Sorin
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Quidel Ortho Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Meridian Bioscience
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Luminex Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Gen Mark Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Alere
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ora Sure Technologies
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Chembio Diagnostic Systems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Trinity Biotech
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sekisui Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 EKF Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Thermo Fisher Scientific
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 T2 Biosystems
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Becton Dickinson
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Cepheid
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Roche Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 bio Merieux
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Abbott Laboratories
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us